Home » Prometheus Launches Test to Predict Risk of Complications From Crohn’s
Prometheus Launches Test to Predict Risk of Complications From Crohn’s
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, Tuesday announced the commercial launch of its proprietary PROMETHEUS Crohn’s Prognostic test.
TheStreet
TheStreet
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May